LivaNova Future Growth
Future criteria checks 3/6
LivaNova is forecast to grow earnings and revenue by 48.2% and 4.4% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 7.7% in 3 years.
Key information
48.2%
Earnings growth rate
33.7%
EPS growth rate
Medical Equipment earnings growth | 16.8% |
Revenue growth rate | 4.4% |
Future return on equity | 7.7% |
Analyst coverage | Good |
Last updated | 16 Dec 2024 |
Recent future growth updates
Recent updates
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 12LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 03LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital
Oct 31LivaNova: Economics Should Start Making Sustained Improvements
Oct 18Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?
Oct 02LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares
Aug 21LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger
Jul 30At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?
Jul 04Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?
Jun 13LivaNova: Focus Is Paying Off
May 12These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,387 | 120 | N/A | N/A | 10 |
12/31/2025 | 1,313 | 40 | N/A | N/A | 10 |
12/31/2024 | 1,245 | 0 | N/A | N/A | 10 |
9/30/2024 | 1,242 | 24 | 109 | 158 | N/A |
6/30/2024 | 1,210 | -17 | 85 | 125 | N/A |
3/31/2024 | 1,185 | -32 | 30 | 64 | N/A |
12/31/2023 | 1,154 | 18 | 40 | 75 | N/A |
9/30/2023 | 1,118 | 3 | 8 | 40 | N/A |
6/30/2023 | 1,085 | -97 | 29 | 57 | N/A |
3/31/2023 | 1,045 | -82 | 36 | 65 | N/A |
12/31/2022 | 1,022 | -86 | 43 | 70 | N/A |
9/30/2022 | 1,017 | -93 | 60 | 85 | N/A |
6/30/2022 | 1,018 | -29 | 51 | 73 | N/A |
3/31/2022 | 1,028 | -102 | 86 | 109 | N/A |
12/31/2021 | 1,035 | -136 | 77 | 103 | N/A |
9/30/2021 | 1,035 | -414 | 82 | 106 | N/A |
6/30/2021 | 1,022 | -385 | 59 | 91 | N/A |
3/31/2021 | 939 | -417 | 11 | 46 | N/A |
12/31/2020 | 934 | -347 | -114 | -79 | N/A |
9/30/2020 | 952 | -208 | -150 | -114 | N/A |
6/30/2020 | 981 | -161 | -234 | -199 | N/A |
3/31/2020 | 1,076 | -102 | -230 | -199 | N/A |
12/31/2019 | 1,084 | -158 | -116 | -91 | N/A |
9/30/2019 | 1,094 | -222 | -106 | -73 | N/A |
6/30/2019 | 1,097 | -260 | 19 | 55 | N/A |
3/31/2019 | 1,107 | -211 | 63 | 102 | N/A |
12/31/2018 | 1,107 | -178 | 82 | 120 | N/A |
9/30/2018 | 1,088 | 0 | 82 | 117 | N/A |
6/30/2018 | 1,068 | 33 | N/A | 108 | N/A |
3/31/2018 | 1,036 | 59 | N/A | 79 | N/A |
12/31/2017 | 1,012 | 54 | N/A | 91 | N/A |
9/30/2017 | 795 | 121 | N/A | 114 | N/A |
6/30/2017 | 840 | 92 | N/A | 109 | N/A |
3/31/2017 | 905 | 55 | N/A | 114 | N/A |
12/31/2016 | 965 | 2 | N/A | 90 | N/A |
12/31/2015 | 545 | -22 | N/A | -14 | N/A |
10/18/2015 | 295 | 14 | N/A | 87 | N/A |
7/24/2015 | 301 | 57 | N/A | 80 | N/A |
4/24/2015 | 292 | 58 | N/A | 80 | N/A |
1/23/2015 | 292 | 66 | N/A | 80 | N/A |
10/24/2014 | 288 | 63 | N/A | 75 | N/A |
7/25/2014 | 285 | 60 | N/A | 63 | N/A |
4/25/2014 | 282 | 55 | N/A | 54 | N/A |
1/24/2014 | 276 | 48 | N/A | 61 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LIVN's forecast earnings growth (48.2% per year) is above the savings rate (2.6%).
Earnings vs Market: LIVN's earnings (48.2% per year) are forecast to grow faster than the US market (15.2% per year).
High Growth Earnings: LIVN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LIVN's revenue (4.4% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: LIVN's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LIVN's Return on Equity is forecast to be low in 3 years time (7.7%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 08:57 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LivaNova PLC is covered by 30 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Rescott | Baird |
Michael Polark | Baird |
Matt Miksic | Barclays |